Force Factor VolcaNO 120 Capsules | Nitric Oxide Booster
Force Factor VolcaNO is a Nitric Oxide Boosting supplement. While this may seem like an unassuming capsule, VolcaNO delivers energy, power, strength, and endurance along with insane vascularity & muscle fullness.
Force Factor VolcaNO Product Highlights
- Increased Muscle Fullness & Vascularity
- Featuring a Patented Creatine Formulation
- Increased Muscle & Strength
- Increased Stamina & Endurance
- Featuring Clinical Studied Ingredients
- Made in the USA
Force Factor VolcaNO Key Ingredients:
Does Force Factor VolcaNO Contain Creatine?
Yes, force factor contains CON-CRET branded Creatine HCL, however it's part of the formulas Creatine Strength Complex which is a blend of creatine, L-Methionine, and L-Glycine so we don't know the exact dosage.
Does Force Factor VolcaNO Contain Stimulants?
No, this is a stimulant free formula and does not contain caffeine, DMHA, Yohimbe or other stimulants.
What Results Can I Expect Taking Force Factor VolcaNO?
When you start taking VolcaNO you should expect increased muscle pumps, enhanced veins and vascularity, as well as additional strength, power, and endurance.
On training days take 2-4 capsules with breakfast and another 2-3 capsules
Force Factor VolcaNO 120 Capsules Supplement Facts
Serving Size: 2 Capsules
Servings Per Container: 60
Vitamin B6 (as Pyridoxine HCL) 1mg
Nitric Oxide Muscle Matrix 1520mg
Vein-Annihiliating Energy Blend
L-Citrulline, Agmapure (Agmatine Sulfate), L-Norvaline
Creatine Strength Complex
CON-CRET (Creatine HCL), L-Methionine, L-Glycine
*Daily Value (DV) Not Established
Other Ingredients: Gelatin, Silica, Magnesium Stearate, Titanium Dioxide, FD&C Red #40, FD&C Blue #1
Store in a cool dry place after opening.
Cooper R, Naclerio F, Allgrove J, Jimenez A. Creatine supplementation with specific view to exercise/sports performance: an update. J Int Soc Sports Nutr. 2012;9(1):33. Published 2012 Jul 20. doi:10.1186/1550-2783-9-33
Xu W, Gao L, Li T, Shao A, Zhang J. Neuroprotective Role of Agmatine in Neurological Diseases. Curr Neuropharmacol. 2018;16(9):1296-1305. doi:10.2174/1570159X15666170808120633